Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy
Kyverna taps ElevateBio to secure commercial supply of autoimmune CAR-T therapy. Reported by BioSpace on 2026-07-29.
ElevateBio
Private
Cell and gene therapy company powering industry with integrated technologies and manufacturing. BaseCamp platform offers cGMP manufacturing for viral vectors, RNA, and cell therapy. 25M funding. Partnerships with Allovir and HighPassBio.
Company Info
Upcoming Milestones & Key Dates
Q3/Q4 2026
Earnings
Q2 2026 corporate update
Recent News
Leadership Team
Careers & Job Openings